Search Results - "Dalpiciclib"

Clinical efficacy and therapy response prediction of neoadjuvant dalpiciclib plus letrozole in postmenopausal patients with HR+/HER2- stage II-III breast cancer (DARLING 01): a single-arm, open-label, exploratory study

Lina Zhang, Yueping Liu, Chao Yang, Jie Ma, Yuntao Li, Ruizhen Luo, Jianjun Han, Xiaochun Wang, Zhisheng Zhang, Li Ma, Haifeng Cai, Xiangshun Kong, Zunyi Wang, Xinping Zhou, Jiajie Shi, Yanshou Zhang, Meiqi Wang, Jiaxing Wang, Cuizhi Geng

electronic resource

View item

Dalpiciclib plus aromatase inhibitor versus neoadjuvant chemotherapy for ER-positive, HER2-negative breast cancer

Haoqi Wang, Guoyu Zhang, Wei Gao, Sainan Li, Shan Yang, Xi Zhang, Jiaxing Wang, Chunxiao Li, Shan Gao, Cuizhi Geng

electronic resource

View item; View item

The efficacy and safety of dalpiciclib, a cyclin-dependent kinase 4/6 inhibitor, in patients with advanced head and neck mucosal melanoma harboring CDK4 amplification

Shi, Chaoji^{Aff1, Aff2, Aff3, Aff4}, Ju, Houyu^{Aff1, Aff2, Aff3}, Zhou, Rong^{Aff1, Aff2, Aff3}, Xu, Shengming^{Aff1, Aff2, Aff3}, Wu, Yunteng^{Aff1, Aff2, Aff3}, Gu, Ziyue^{Aff1, Aff2, Aff3}, Wang, Ying, Chen, Wanling^{Aff2, Aff3}, Huang, Xinyi^{Aff2, Aff3}, Han, Yong^{Aff1, Aff2, Aff3}, Sun, Shuyang^{Aff1, Aff2, Aff3}, Li, Chuwen^{Aff1, Aff2, Aff3}, Wang, Min^{Aff2, Aff3, Aff6}, Zhou, Guoyu^{Aff1, Aff2, Aff3}, Zhang, Zhiyuan^{Aff1, Aff2, Aff3, Aff4, IDs1291602403431x_cor15}, Li, Jiang^{Aff2, Aff3, Aff6, IDs1291602403431x_cor16}, Ren, Guoxin^{Aff1, Aff2, Aff3, IDs1291602403431x_cor17}

A meta-analysis and systematic review of different cyclin-dependent kinase 4/6 inhibitors in breast cancer

Jialin Zhang, Xinyu Xu, Yeyue Zhou, Jingyang Su, Jue Wang

electronic resource

View item; View item

A study protocol for an open‐label, single‐arm, single‐center phase I clinical study on tolerability, safety, and efficacy of dalpiciclib combined with apatinib in the treatment of patients with advanced or metastatic sarcoma

Huiying Huang, Hua Zhang, Baoshan Cao

electronic resource

View item; View item

Safety and quality of life of CDK4/6 inhibitors therapy for hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: a multicenter cross-sectional survey in China

Yang, Benlong^{Aff1, Aff2}, Sun, Zhengkui^Aff3, Ouyang, Quchang^Aff4, Tong, Zhongsheng, Wang, Shu, Li, Hongyuan, Niu, Zhaofeng, Chen, Yiding, Ma, Lin-xiaoxi^{Aff1, Aff2}, Wang, Haoqi, Tang, Mu, Hu, Zheyu, Gao, Xueqiang, Wang, Xu, Xie, Fei, Cheng, Qiao, Shen, Yong, Geng, Cuizhi^{Aff10, IDs12885025142238_cor1}, Wang, Haibo^{Aff11, IDs12885025142238_cor2}, Wu, Jiong^{Aff1, Aff2, IDs12885025142238_cor3}

Efficacy and safety of first-line CDK4/6 inhibitors plus AI therapy for patients with HR +/HER2- advanced breast cancer: a network meta-analysis

Kang, Yanrong^Aff1, Han, Bing^Aff2, Kong, Yongmei, Liu, Shuai^{Aff4, IDs1288502514194w_cor1}, Zhang, Nan^{Aff4, IDs1288502514194w_cor2}

Breast Cancer—Therapeutic Challenges, Research Strategies and Novel Diagnostics

Nabieva, Naiba

application/octet-stream

A pilot trial of neoadjuvant pyrotinib plus trastuzumab, dalpiciclib, and letrozole for triple‐positive breast cancer

Shiwen Huo, Jinqi Xue, Shuo Wang, Huilian Shan, Guanglei Chen, Nan Niu, Yimin Wang, Fang Qiu, Yi Zhao, Fei Xing, Xinyu Zheng, Wei Tu, Ke Li, Hai Zhao, Meiyue Tang, Qianshi Xu, Chao Liu, Yafei Zhao, Xiaofan Jiang, Zheng Pang, Keliang Zhang, Dianlong Zhang, Zhe‐Sheng Chen, Caigang Liu

electronic resource

View item

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.